• Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy 

  Cheah, CY; Dickinson, M; Hofman, MS; George, A; Ritchie, DS; Prince, HM; Westerman, D; Harrison, SJ; Burbury, K; Wolf, M; ... (SPRINGER, 2014-07-01)

  The optimum follow-up of patients with transformed indolent lymphoma (TrIL) is not well defined. We sought to determine the utility of surveillance positron emission tomography-computed tomography (PET-CT) in patients with ...

• Effects of Tamoxifen and oestrogen on histology and radiographic density in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers 

  Chew, GL; Huo, CW; Huang, D; Blick, T; Hill, P; Cawson, J; Frazer, H; Southey, MC; Hopper, JL; Britt, K; ... (SPRINGER, 2014-11-01)

  Mammographic density (MD) is a strong risk factor for breast cancer. It is altered by exogenous endocrine treatments, including hormone replacement therapy and Tamoxifen. Such agents also modify breast cancer (BC) risk. ...

• Development of a hospital-based patient-reported outcome framework for lung cancer patients: a study protocol 

  Moloczij, N; Gough, K; Solomon, B; Ball, D; Mileshkin, L; Duffy, M; Krishnasamy, M (BIOMED CENTRAL LTD, 2018-01-11)

  BACKGROUND: Patient-reported outcome (PRO) data is central to the delivery of quality health care. Establishing sustainable, reliable and cost-efficient methods for routine collection and integration of PRO data into health ...

View more